v3.25.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share
11. Net Loss Per Share

Loss Per Share

Basic loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed based on the sum of the weighted average number of common shares and dilutive common shares outstanding during the period. As described in Note 8 – Stockholders' Equity, Earnout Shares issued in connection with the Business Combination are subject to vesting based on the VWAP of common shares during the earnout period. The Earnout Shares are excluded from the calculation of basic and diluted weighted-average number of common shares outstanding until vested.

The following table outlines the basic and diluted net loss per share for the three and six months ended June 30, 2025 and 2024:

 Three Months Ended June 30,Six Months Ended June 30,
(in thousands, except per share data)2025202420252024
Net loss$(15,875)$(13,631)$(34,075)$(32,592)
Weighted-average shares outstanding, basic and diluted106,148 101,456 105,886 101,106 
Net loss per share, basic and diluted$(0.15)$(0.13)$(0.32)$(0.32)

The following table outlines common share equivalents which were excluded from the computation of diluted net loss per share, as the effect of their inclusion would be anti-dilutive or the share equivalents were contingently issuable as of each period presented:

 June 30,
20252024
Options to purchase common stock issued and outstanding(1)
23,654,207 22,236,056 
Earnout shares16,292,542 16,292,542 
Private placement warrants
8,233,333 8,233,333 
Public warrants
7,666,667 7,666,667 
Restricted stock units issued and outstanding
2,027,573 2,179,919 
Forward purchase warrants1,666,667 1,666,667 
Backstop warrants1,445,489 1,445,489 
Shares expected to be purchased under employee stock purchase plan1,036,822 862,289 
Total anti-dilutive shares62,023,300 60,582,962 
_____________
(1)Outstanding stock options include awards outstanding to employees of Ligand.